出版年月 |
作者 |
期刊名稱 |
論文名稱 |
2024.06 |
江世楷、張為超、陳洵一*、張玲菊* |
Cell and Bioscience |
CDK7/CDK9 mediates transcriptional activation to prime paraptosis in cancer cells |
2024.06 |
李瑋、許斐婷、賴彥合、黃淑柔、許士超、江智聖*、鄭隆賓*、徐偉成*、陳三元* |
Advanced Science |
Manipulating the Crosstalk between Cancer and Immunosuppressive Cells with Phototherapeutic Gold-Nanohut for Reprogramming Tumor Microenvironment |
2024.05 |
林瑋德、徐媛曼* |
Enviromental Toxicology |
Influence of administration timing of San-Huang-Xie-Xin-Tang treatment on attenuating Salmonella enterica serovar Typhimurium infection |
2024.04 |
楊家欣、劉鼎元、呂幸芳、蔡士彰、廖文伶、邱宇任、王裕文、蔡輔仁* |
Molecular Medicine Reports |
Genome-wide association study and polygenic risk scores predict psoriasis and its shared phenotypes in Taiwan |
2024.03 |
賴光啟、郭昭麟、彭淑芬、黃雯雯*、* |
Enviromental Toxicology |
Allyl isothiocyanate induces DNA damage and inhibits DNA repair-associated proteins in a human gastric cancer cells in vitro |
2024.03 |
鄭自君、廖祐承、陳莉菁、何元順* |
Biomaterials |
RNA four-way junction (4WJ) for spontaneous cancer-targeting, effectivetumor-regression, metastasis suppression, fast renal excretion andundetectable toxicity |
2024.03 |
陳美吟、康一龍* |
Surfaces and Interfaces |
The Evaluation of DNA Aptamer Monolayers on Silicon Surface for the Promotion of Cell-Surface Interaction |
2024.02 |
、鄭自君、陳莉菁、何元順* |
Molecular Pharmaceutics |
In Vitro and In Vivo Evaluation of the Pathology and Safety Aspects of Three- and Four-Way Junction RNA Nanoparticles |
2024.01 |
賴光啟、闕甫伈、馬易世、周育誠、陳兆群、廖慶龍、黄怡萍*、彭淑芬* |
Enviromental Toxicology |
Phenethyl isothiocyanate and irinotecan synergistically induce cell apoptosis in colon cancer HCT 116 cells in vitro |
2024.01 |
山口浩史*、張玲菊、陳郁夫、蕭宇君、吳承修、洪明奇* |
International Journal of Biological Sciences |
MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer |
2024.01 |
黄怡萍、葉峻安、馬易世、陳柏源、賴光啟、連金城*、謝文聰* |
Enviromental Toxicology |
PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro |
2024.01 |
許斐婷、劉國慶 |
Anticancer Research |
Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells |
2023.12 |
蘇文琪、王韋然、宋瑛琪、李欣蓉、洪明奇、賴明昭* |
ANTIVIRAL RESEARCH |
Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization |
2023.12 |
黃裕鍇、鄭維中、郭婷婷、楊顓丞、吳永昌、吳恒祥、羅佳茜、謝知穎、黃思澄、陸志豪、、劉士任、李易撰、林精湛、沈家寧、洪明奇、林肇堂、葉俊杰*、佘玉萍* |
Nature Cancer |
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy |
2023.11 |
Shaneek Nato、李易撰、山口浩史、陳筱凡*、洪明奇* |
Biomedicines |
Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry |
2023.11 |
彭姵華、陳紀琳、吳恒祥、楊文豪、林莉婕、賴玠羽、張正守、許嘉凌、吳函蒼、許斐婷*、鄭維中*、許凱文* |
Cancer Cell International |
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis |
2023.11 |
呂琬琪、李易撰、張君如*、楊哲彥* |
Cell Metabolism |
Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer |
2023.11 |
吳承修、李易撰、彭馨蕾、、陳筱凡、薛博仁、王韋然、張為超、王紹椿、洪明奇* |
Cell and Bioscience |
Coffee as a dietary strategy to prevent SARS-CoV-2 infection |
2023.11 |
張瀚升、鄭自君、廖佑承、杜世興、吳志雄、張榮善、潘敏雄、陳莉菁*、何元順* |
Food Science and Human Wellness |
Qu+A1:D20ercetin inhibits truncated isoform of dopamine- and cAMP-regulated phosphoprotein as adjuvant treatment for Trastuzumab therapy resistance in HER2-positive breast cancer |